High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 149-155

  Haas, R ^a   Moos, M ^a   Mohle R ^a   Dohner H ^a   Witt, B ^a   Goldschmidt, H ^a   Murea, S ^a   Flentje, M ^b   Wannenmacher, M ^a   Hunstein, W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

G CSF; High dose therapy; Low grade non Hodgkin's lymphoma; Peripheral blood progenitor cell transplantation

Indexed keywords

BLEOMYCIN; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ARTICLE; AUTOGRAFT; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MULTIPLE ORGAN FAILURE; NEUTROPENIA; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; BONE MARROW DISEASES; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FILGRASTIM; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKAPHERESIS; LIFE TABLES; LYMPHOMA, FOLLICULAR; LYMPHOMA, LOW-GRADE; MALE; MELPHALAN; MIDDLE AGED; MITOXANTRONE; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 13344270371     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rosenberg SA. The low-grade non-Hodgkin's lymphomas: Challenges and opportunities. J Clin Oncol 1985; 3: 299-310.
2. Rohatiner AZS, Lister TA. Management of follicular lyrnphoma. Curr Opin Oncol 1994; 6: 473-479.
3. Brittinger G, Bartels H, Common H et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel lymphoma study group. Hematol Oncol 1984; 2: 269-306.
4. Horning SJ. Treatment approaches to the low-grade lymphomas. Blood 1994; 83: 881-884.
5. Scheuten HC, Bierman PJ, Baughan WP et al. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 1989; 74: 2579-2584.
6. Petersen FB, Appelbaum FR, Hill R et al. Autologous transplantation for malignant lymphoma: a report of 101 cases from Seattle. J Clin Oncol 1990; 8; 638-647.
7. Freedman AS, Takvorian T, Andersen KC et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990; 8: 784-791.
8. Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524-2529.
9. Colombat P, Binet C, Linassier C et al. High dose chemotherapy with autologous marrow transplantation in follicular lymphoma. Leuk Lymphoma 1992; 7: 3-6.
10. Rohatiner AZS, Freedman AS, Nadler L et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 1994; 5 (Suppl 2): 143-146.
11. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
12. Haas R, Hohaus S, Egerer G et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992; 9: 459-465.
13. Hohaus S, Goldschmidt H, Ehrhardt R et al. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21: 508-514.
14. Liberti G, Pearce R, Taghipour G et al. Comparison of peripheral blood stem cells and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT registry data. Ann Oncol 1994; 5 (Suppl 2): 151-153.
15. Fielding AK, Watts MJ, Goldstone AH. Peripheral blood progenitor cells versus bone marrow. J Hematotherapy 1994; 3: 299-304.
16. Vose JM, Anderson JR, Kessinger A et al. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1846-1851.
17. Haas R, Moos M, Karcher A et al. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 1685-1692.
18. Ho AD, Del Valle F, Haas R et al. Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma. Semin Oncol 1990; 17 (Suppl. 10): 14-19.
19. Craig W, Kay R, Cutler RL et al. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 1993; 177: 1331-1342.
20. + hematopoietic progenitor cells. Blood 1995; 85: 1936-1943.
21. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
22. Jones RJ, Celano P, Sharkis SJ, Sensenbrenner LL. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 1989; 73: 397-401.
23. Bensinger WI, Longin K, Appelbaum FR et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Hematol 1994; 87: 825-831.
24. Rohatiner AZS, Johnson PWM, Price CGA et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177-1184.
25. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
26. Gribben JG, Neuberg D, Barber M et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994; 83: 3800-3807.
27. McLaughlin P, Fuller LM, Velasquez WS et al. Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. J Clin Oncol 1987; 5: 867-874.
28. Unterhalt M, Koch P, Pfreundschuh M et al. Prednimustine, mitoxantrone (PMM) versus cyclophosphamide, vincristine. prednisone (COP) for the treatment of advanced low-grade non-Hodgkin lymphoma. Blood 1994; 84: 168a (abstr. 656).
29. Dana BW, Dahlberg S, Nathwani BN et al. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. J Clin Oncol 1993; 11: 644-651.